Stryker Corporation Deciding whether to keep outsourcing or in-source PCBs Stryker Corporation has 3 different options regarding the supply of needed PCBs. Option 1: contemplates the fact of keeping the same suppliers but with significant changes in order to assure continuous supply of PCBs and quality. No investment is needed. Option 2: establishing a partner with a single supplier. This way there would be a sole supplier for Stryker established in a new facility near them‚ this would give
Premium Depreciation Investment Net present value
risks Benefits: (1). Controlled quality By choosing option 3‚ Stryker Corporation can control the quality of PCB by itself. PCB manufactured in its own facility can meet Stryker’s quality requirement better than those from different contract manufacturers. Moreover‚ the quality can be more stable. Stryker would not suffer from the risk of contract manufacturers’ bankruptcy any longer. (2). Reduced cost and higher efficiency Stryker Corporation can relief its human resource from looking for new
Premium Depreciation Capital expenditure 1922
numerous times before releasing it to the public‚ as this would have allowed them to fix production issues. The FDA‚ for example‚ issued three warning letters to the company and it appears that they did not have the sense of urgency to fix the problems. Stryker would now have to uncover the specific issues of the prototype and implement a strategy to improve its overall functioning. Moreover‚ they need to ensure that they have solved all issues with the implant prior to releasing a new prototype. In conclusion
Premium
#3 suggests Stryker Corporation to build its own facility to manufacture its own PBCs. Under the current situation that some contract manufacturers have weak performance in quality and delivery‚ the benefits of this option are obvious as following: First of all‚ option #3 promised the highest degree of control over quality and delivery‚ which can solve the major problem that Stryker has faced with recently. On the other hand‚ self-manufacturing offers an opportunity for Stryker to carry out
Premium Depreciation Generally Accepted Accounting Principles Capital expenditure
Summary of Stryker Corp: Stryker Corporation is a medical technology firm‚ which develops and manufactures: medical implants‚ surgical and imaging technologies‚ as well as patient handling and emergency medical equipment produced for the healthcare industry. Stryker competes in the Medical instruments industry. The medical instrument industry provides consumers and society with many varying products and services that use technology to meet their health needs. More specifically Stryker instruments
Premium Medical technology Medical device Medical equipment
barriers to entry. In addition‚ during periods of economic uncertainty‚ medical equipment has seen continued gains. We are evaluating two companies within the Medical Equipment Industry: Stryker Corp. (NYSE:SYK) and Medtronic Inc. (NYSE:MDT). Our main goal is to analyze which company might make a better investment. Stryker Corp (NYSE: SYK) We are recommending a buy at a price target of: $78.90 Market data as of: 07/18/2007 STOCK PRICE: $64.52 ANNUAL DIVIDEND: $0.33 MARKET CAP: $26.58B PRICE
Premium Revenue Medical device Medical technology
1. Discuss the extent to which the characteristics of well-functioning‚ effective groups accurately describe the Freiburg hip replacement navigation system team. The purpose for teams is to combine a group of members to work together to accomplish certain goals that cannot be achieved effectively by an individual. Although each team member’s abilities were important‚ how those abilities fit together was equally important. Welte assembled a team of the best people at Freiburg in operations‚ computer-aided
Premium Hip replacement Hip Orthopedic surgery
CASE STUDY: STRYKER Teamwork Challenges at Stryker Corporation The Stryker Corporation was built on innovation. “When Dr. Homer Stryker‚ an orthopedic surgeon from Kalamazoo‚ Michigan‚ found that certain medical products were not meeting his patients’ needs‚ he invented new ones. As interest in these products grew‚ Dr. Stryker started a company in 1941 to produce them. The company’s goal was to help patients lead healthier‚ more active lives through products and services that make surgery and recovery
Premium Medicine Management Physician
DardenBusinessPublishing:210258 UVA-F-1341 This document is authorized for use only by shuang lin at UMD. Please do not copy or redistribute. Contact permissions@dardenbusinesspublishing.com for questions or additional permissions. MARKOV’S TRILEMMA George Markov eagerly awaited his first day at his new job with Athena Asset Management in a major metropolitan area in the northeastern United States. His future boss had given him a list of questions that would prepare him well for the
Premium Standard deviation Pearson product-moment correlation coefficient Microsoft Excel
and #2? Benefit: a. Better performance in management‚ quality and delivery. When PCB is in-souring facility‚ the management team of Stryker Corporation can directly control the production process‚ which is more efficient and could obtain better quality in products. Secondly‚ when the production of PCB is in-sourcing‚ it will be much easier for Stryker Corporation to make a delivery plan of PCB. This will considerably reduce the logistic losses. b. More flexible in outputs. Under current
Premium Costs Cost Free cash flow